Finalized Draft LCDs

The following Part A draft LCDs have been finalized and can be viewed on our web site. Following a forty-five day notice period, which begins August 1, 2008, the LCDs will become effective September 15, 2008.

Drugs and Biologicals: Palonosetron HCL Injection (Aloxi™)
Drugs and Biologicals: Octreotide Acetate for Injectable Suspension (Sandostatin® LAR Depot)
Medicine: Wireless Capsule Imaging
Surgery: Upper Gastrointestinal Endoscopy

Draft LCDs can be found on our Web site. There were no comments for these Draft LCDs.

Page last updated: July 11, 2008